NCT02711826: A reported trial by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT02711826 |
|---|---|
| Title | Treg Adoptive Therapy in Subclinical Inflammation in Kidney Transplantation (CTOT-21) |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Sept. 20, 2016 |
| Completion date | Aug. 4, 2023 |
| Required reporting date | Aug. 3, 2024, midnight |
| Actual reporting date | June 6, 2024 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |